Panacea Biotec · NSE: PANACEABIO · BSE: 531349
Q4 FY19 results · Jan–Mar 2019
Panacea Biotec reported revenue from operations of ₹29.26 crore and net profit of ₹183.90 crore for Q4 FY19 (Jan–Mar 2019), on a standalone basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 29.26 | — | — | 113.85 | −74.3% |
| Other income | 1.13 | — | — | 4.12 | −72.6% |
| Total income | 30.39 | — | — | 117.97 | −74.2% |
| Profit before tax | 218.69 | — | — | (20.36) | Turned profit |
| Net profit for the period | 183.90 | — | — | (23.02) | Turned profit |
| EPS, basic (₹) | 30.02 | — | — | (3.76) | Turned profit |
| Net margin (%) | 628.5 | — | -20.2 |
Standalone
- Filed with BSE
- 12 Jun 2019, 12:58 IST
- Board meeting
- 30 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE